Cost-Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK

Emery, P, van Keep, M, Beard, SM et al. (6 more authors) (2017) Cost-Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK. In: Value in Health. ISPOR 20th Annual European Congress, 04-08 Nov 2017, Glasgow, Scotland. Elsevier , A534-A534.

Metadata

Authors/Creators:
  • Emery, P
  • van Keep, M
  • Beard, SM
  • Graham, CN
  • Miles, L
  • Jugl, SM
  • Gunda, P
  • Halliday, A
  • Marzo-Ortega, H
Dates:
  • Published (online): 20 October 2017
  • Published: 20 October 2017
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 15 May 2018 13:56
Last Modified: 18 May 2018 13:42
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/j.jval.2017.08.765
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)